The purpose of this study is to demonstrate the diversity of plant-based therapies currently used in different countries and regions around the world for the treatment and management of SARS-CoV-2 (COVID 19).

The majority of the world’s population living in the developing world rely on herbal medicine as a primary source of healthcare. While COVID 19 is a global pandemic, Western biomedical perspectives often dominate the media and marginalize other forms of knowledge. We feel strongly in the validity of herbal medicine and that primary source authorship has a rightful place alongside Western scholarship. This survey aims to create a platform for new methods of cross-cultural, collaborative, and academic research.

Anyone with knowledge of plant-based treatments being used or studied within a particular region for the prevention and treatment of COVID19 may contribute. This may include, but is not limited to medical doctors, researchers, clinicians, ethnobotanists, herbal practitioners, traditional healers, and laypersons with specialized plant-knowledge that are trusted to treat family and community members.

Data collected will be compiled into an open-access, academic research publication for educational purposes. We plan to fast-track this collaborative research project with a prominent medical or ethnobotanical journal by the start of the new year.

All contributions will be acknowledged in aggregate. Those contributing full information for their region of expertise will be listed as a co-author for their collaboration. Should you wish for your contribution to remain anonymous, please let us know.

You may participate in this study by filling out this questionnaire. It may be filled out entirely or questions may be used selectively as a guide. If the questionnaire is not applicable to your situation or area of study, please write an independent narrative that accurately reflects your research, experience, or region of expertise and submit it to [email protected]

The safety and protection of all intellectual property shared for the purpose of this study is vitally important to us. The Global Covid19 Medicinal Plant Project is in compliance with the International Society of Ethnobiology Code of Ethics (http://ethnobiology.net/code-of-ethics/) and includes an IPR statement. The utilization of any primary source information other than its intended academic purposes (including but not limited to non-commercial genetic resource research, the creation of products manufactured for commercial use and resale, etc.) are all strictly prohibited without the consent of the original source of that information. Any utilization of this data for unintended purposes or commercialized use is subject to mutually negotiated and concluded terms between all parties via an Access and Benefit Sharing Agreement (ABSA) as defined in the Convention on Biological Diversity and the Nagoya Protocol. The protocol covers traditional knowledge associated with genetic resources that are covered by the CBD and the benefits arising from its utilization.) https://www.cbd.int/abs/doc/protocol/nagoya-protocol-en.pdf

This study is for academic purposes only. All contributions to this paper are volunteer submissions. No participants, including the creators of this study, will be paid for their contributors or profit financially from the subsequent publication of this work.

Yes. We currently have translations for the questionnaire being prepared in both Spanish, and French. This project is global in nature, however, and we aim for the greatest inclusivity possible. Please let us know what language/s would be beneficial to you or your community. If you would like to contribute to this research project by offering translation services, please contact us at [email protected]